Skip to Main Content

Intuitive Surgical Inc.

ISRG Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
ISRG Income Statement
ISRG Balance Sheet
ISRG Cash Flow

Recent trades of ISRG by members of U.S. Congress

Politician Type Traded
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jul. 22, 2024
Greg Landsman House / D Sale $1,001 - $15,000 Jul. 17, 2024
Greg Landsman House / D Sale $15,001 - $50,000 Jul. 17, 2024
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jun. 25, 2024
Greg Landsman House / D Purchase $15,001 - $50,000 Jun. 20, 2024
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jan. 29, 2024
Josh Gottheimer House / D Sale $1,001 - $15,000 Oct. 27, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct. 24, 2023
Greg Landsman House / D Sale $1,001 - $15,000 Oct. 12, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep. 26, 2023
Greg Landsman House / D Sale $1,001 - $15,000 Aug. 02, 2023
William R. Keating House / D Purchase $1,001 - $15,000 Jul. 20, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 May. 30, 2023
Greg Landsman House / D Purchase $1,001 - $15,000 May. 30, 2023
Greg Landsman House / D Purchase $1,001 - $15,000 May. 04, 2023
Josh Gottheimer House / D Purchase $1,001 - $15,000 May. 01, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Mar. 06, 2023
Greg Landsman House / D Purchase $1,001 - $15,000 Feb. 01, 2023
Daniel S. Goldman House / D Purchase $1,001 - $15,000 Jan. 31, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Oct. 12, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Sep. 12, 2022
John R. Curtis House / R Sale $1,001 - $15,000 Jun. 28, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Jun. 10, 2022
Donald S. Beyer, Jr. House / D Sale $15,001 - $50,000 Feb. 28, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Feb. 23, 2022
Josh Gottheimer House / D Sale $1,001 - $15,000 Jan. 26, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec. 01, 2021
John R. Curtis House / R Purchase $1,001 - $15,000 Jun. 22, 2021
Kathy E. Manning House / D Sale $1,001 - $15,000 May. 04, 2021
Josh Gottheimer House / D Sale $1,001 - $15,000 Feb. 23, 2021
Peter Meijer House / R Sale $1,001 - $15,000 Feb. 16, 2021
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 05, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Jul. 14, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 07, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 01, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Apr. 27, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Apr. 17, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Apr. 02, 2020
John R. Curtis House / R Purchase $1,001 - $15,000 Mar. 27, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan. 28, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 23, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 09, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 22, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 19, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 20, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Jul. 16, 2019
James M. Inhofe Senate / R Sale (Full) $15,001 - $50,000 May. 10, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Apr. 15, 2019
Jack Reed Senate / D Sale (Full) $1,001 - $15,000 Feb. 28, 2019
Jack Reed Senate / D Sale (Full) $1,001 - $15,000 Feb. 04, 2019
ISRG Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ISRG Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ISRG Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by ISRG's directors and management

Government lobbying spending instances

  • $70,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Health Issues
  • $70,000 Jul 22, 2024 Issue: Health Issues
  • $70,000 Apr 19, 2024 Issue: Health Issues
  • $120,000 Jan 22, 2024 Issue: Health Issues
  • $100,000 Oct 20, 2023 Issue: Health Issues
  • $70,000 Jul 20, 2023 Issue: Health Issues
  • $280,000 Apr 20, 2023 Issue: Health Issues
  • $50,000 Jan 20, 2023 Issue: Health Issues
  • $290,000 Oct 20, 2022 Issue: Health Issues
  • $60,000 Jul 20, 2022 Issue: Health Issues
  • $60,000 Apr 20, 2022 Issue: Health Issues
  • $60,000 Jan 20, 2022 Issue: Health Issues
  • $270,000 Oct 20, 2021 Issue: Health Issues
  • $60,000 Jul 20, 2021 Issue: Health Issues
  • $60,000 Apr 20, 2021 Issue: Health Issues
  • $60,000 Jan 20, 2021 Issue: Health Issues
  • $60,000 Oct 09, 2020 Issue: Health Issues
  • $60,000 Jul 20, 2020 Issue: Health Issues
  • $60,000 Apr 15, 2020 Issue: Health Issues
  • $60,000 Jan 17, 2020 Issue: Health Issues
  • $90,000 Oct 21, 2019 Issue: Health Issues
  • $60,000 Jul 15, 2019 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Apr 11, 2019 Issue: Science/Technology Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $40,000 Jan 17, 2019 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Oct 15, 2018 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Jul 17, 2018 Issue: Science/Technology Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $40,000 Apr 16, 2018 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Jan 22, 2018 Issue: Medicare/Medicaid Science/Technology Health Issues Medical/Disease Research/Clinical Labs
  • $40,000 Oct 12, 2017 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Jul 19, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Science/Technology
  • $30,000 Apr 17, 2017 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs Science/Technology
  • $30,000 Jan 19, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues Science/Technology
  • $30,000 Oct 18, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid Science/Technology
  • $30,000 Jul 15, 2016 Issue: Science/Technology Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $30,000 Apr 18, 2016 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Jan 14, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Science/Technology
  • $40,000 Oct 14, 2015 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs Science/Technology
  • $40,000 Jul 17, 2015 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid Science/Technology
  • $40,000 Apr 13, 2015 Issue: Science/Technology Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $40,000 Jan 20, 2015 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs Science/Technology
  • $45,000 Oct 20, 2014 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs Science/Technology
  • $70,000 Jul 19, 2014 Issue: Health Issues
  • $95,000 Jul 08, 2014 Issue: Health Issues
  • $110,000 Apr 10, 2014 Issue: Health Issues
  • $150,000 Oct 17, 2013 Issue: Health Issues
  • $115,000 Jul 12, 2013 Issue: Health Issues
  • $115,000 Apr 17, 2013 Issue: Health Issues
  • $100,000 Jan 17, 2013 Issue: Manufacturing Health Issues
  • $100,000 Oct 16, 2012 Issue: Health Issues
  • $95,000 Jul 17, 2012 Issue: Health Issues
  • $95,000 Apr 16, 2012 Issue: Health Issues
  • $110,000 Jan 19, 2012 Issue: Health Issues
  • $110,000 Oct 14, 2011 Issue: Health Issues
  • $95,000 Jul 18, 2011 Issue: Health Issues
  • $155,000 Apr 19, 2011 Issue: Health Issues
  • $95,000 Jan 19, 2011 Issue: Health Issues
  • $30,000 Oct 28, 2010 Issue: Medicare/Medicaid
  • $20,000 Oct 20, 2010 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 21, 2010 Issue: Medicare/Medicaid
  • $20,000 Jul 20, 2010 Issue: Medicare/Medicaid Health Issues
  • $20,000 Apr 20, 2010 Issue: Medicare/Medicaid Health Issues
  • $30,000 Apr 20, 2010 Issue: Medicare/Medicaid
  • $20,000 Jan 19, 2010 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 10, 2010 Issue: Medicare/Medicaid
  • $20,000 Oct 20, 2009 Issue: Health Issues Medicare/Medicaid
  • $10,000 Jul 17, 2009 Issue: Health Issues Medicare/Medicaid

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Fiber optic shape sensor May. 18, 2010
  • Patent Title: Medical robotic system with different scaling factors Apr. 13, 2010
  • Patent Title: Platform link wrist mechanism Apr. 06, 2010
  • Patent Title: Tele-medicine system that transmits an entire state of a subsystem Mar. 23, 2010
  • Patent Title: Multiaxis counterbalance and positioning system using a spatial linkage Mar. 16, 2010
  • Patent Title: Robotic surgical system with sterile surgical adaptor Feb. 23, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of ISRG in WallStreetBets Daily Discussion

ISRG News

Recent insights relating to ISRG

CNBC Recommendations

Recent picks made for ISRG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ISRG

ISRG Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ISRG Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top